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Liver cancerTribbles homolog 2 (TRIB2) is speciﬁcally regulated by Wnt signaling in liver cancer cells but not in
colon cancer cells. However, whether and how TRIB2 regulates Wnt signaling in liver cancer cells
remains unclear. Here, we report that TRIB2 negatively regulates Wnt activity through a reduction
in protein stability of TCF4 and b-Catenin. Mechanistically, TRIB2 associated-ubiquitin E3 ligases
beta-transducin repeat-containing E3 ubiquitin protein ligase (b-TrCP), COP1 and Smad ubiquitina-
tion regulatory factor 1 (Smurf1) reduced TCF4/b-Catenin expression, and these effects could be
enhanced by TRIB2. Moreover, deletion of the binding regions of these E3-ligases within the TRIB2
protein decreased ubiquitination of TCF4/b-Catenin and reduced nuclear accumulation of b-TrCP,
COP1 and Smurf1, which suggested that TRIB2 regulated-Wnt activity is closely correlated with its
associated E3 ligases.
Structured summary of protein interactions:
TCF4 and TRIB2 colocalize by ﬂuorescence microscopy (1, 2, 3)
TRIB2 and Beta-TrCP colocalize by ﬂuorescence microscopy (View interaction)
TRIB2 and SMURF1 colocalize by ﬂuorescence microscopy (View interaction)
TRIB2 and COP1 colocalize by ﬂuorescence microscopy (View interaction)
TRIB2 physically interacts with COP1 and Beta-TrCP by anti bait coip (View interaction)
Catenin beta and TRIB2 colocalize by ﬂuorescence microscopy (1, 2)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction and progression of lesions [2]. TRIB2 in lung cancer is describedTribbles homolog 2 (TRIB2) is a member of the Tribbles family
of pseudokinase proteins that were originally identiﬁed by their
roles in Drosophila morphogenesis [1]. Previous studies revealed
that TRIB2 is critical during tumorigenesis of multiple cancer types.
TRIB2 overexpression in melanoma contributes to the formationas a potential tumor driver through the downregulation of differ-
entiation-inducing transcription factor CEBPa [3]. TRIB2 in hema-
topoietic tumorigenesis acts as a downstream effecter of Notch
signaling and modulates MAPK signaling [4].
We performed large-scale sequencing analysis in the highly
Wnt signaling activated liver cancer line, HepG2, and the colon
cancer cell line, LS174T, to identify a unique Wnt signaling con-
trolled-target gene in liver cancer cells that contributes to liver
tumorigenesis. We found that TRIB2 was speciﬁcally activated by
TCF4/b-Catenin signaling in HepG2 cells but not LS174T cells,
which suggests that TRIB2 is a liver cancer-speciﬁc Wnt signaling
target [5]. Furthermore, we found that TRIB2 plays a critical role
in liver cancer cell survival and transformation [5]. However,
whether and how TRIB2 inversely regulates Wnt signaling remains
unknown.
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central serine/threonine kinase-like domain (KD), which is the
deﬁning feature of the Tribbles proteins. However, these proteins
are pseudokinases because they lack a catalytic core motif within
the KD [6,7]. Other than the KD, our and previous studies suggest
that TRIB2 functions as a protein that interacts with ubiquitin E3
ligases, such as beta-transducin repeat-containing E3 ubiquitin
protein ligase (b-TrCP), COP1 and TRIM21, at the C terminus,
which modulates the protein stability of downstream targets
[3–5,8,9]. Recently, we discovered that TRIB2 up-regulation in
liver cancer cell lines HepG2, SMMC-7721 and Bel-7402 is due
to a relative lower protein degradation rate compared to the
transformed hepatocyte line HL-7702 [10]. TRIB2 can be phos-
phorylated at S83 by p70S6K before further ubiquitination by
the ubiquitin E3 ligase Smad ubiquitination regulatory factor 1
(Smurf1). Impaired phosphorylation and ubiquitination by
p70S6K and Smurf1 promotes TRIB2 stability and carcinogenic
properties in liver cancer cells [10]. We also described that ubiq-
uitin E3 Smurf1 interacts with the N-terminus of the TRIB2 pro-
tein, and this event is essential for the post-translational
regulation of TRIB2 [10]. This result adds another E3 ligase to
the list of TRIB2 E3 ligase interactions. b-TrCP is one E3 ligase that
mediates protein degradation of b-Catenin [11,12], but whether
and how other TRIB2-associated E3 ligases regulate Wnt signaling
is not clear.
The present study found TRIB2 inhibited Wnt signaling activity
through a facilitation of the ubiquitination of its key factors, TCF4
and b-Catenin, in liver cancer cells. TRIB2 induced a nuclear accu-
mulation of b-Catenin, but this did not lead to the induction of Wnt
activity. However, nuclear accumulation of b-Catenin resulted in
an increase in the opportunity to come into contact with the
TRIB2-associated E3 ligases b-TrCP, COP1 and Smurf1. TRIB2 over-
expression also induced nuclear expression of the above three E3
ligases. Deletion of the binding regions of these E3 ligases within
the TRIB2 protein decreased the ubiquitination of TCF4/b-Catenin
and reduced the nuclear accumulation of b-TrCP, COP1 and Smurf1,
which indicates a close cooperation between TRIB2 and E3 ligases
in the regulation of Wnt activity.2. Materials and methods
2.1. Cell culture and vectors
Liver cancer cell lines, HepG2, Huh7, Bel-7402 and SMMC-
7721, and a transformed hepatocyte line, HL-7702, were cultured
in DMEM supplemented with 10% FBS. ShRNAs against b-TrCP,
COP1 and Smurf1 were purchased from Genechem Biotech LTD
(Shanghai, China). ShRNA against TRIB2 was described and veri-
ﬁed in our previous studies [5,10]. Wild-type (WT) TRIB2-FLAG
was cloned into either a pGIPZ-based lentiviral-expressing vector
or pcDNA3.1(+) vectors. Mutant TRIB2-FLAGs were all cloned into
pcDNA3.1(+) vectors, and the primers for cloning are described in
our previous study [10]. The Del-Smurf1 (plasmid expressing
mutant TRIB2 protein without the amino acid residues (a.a.)
1–5) is equivalent to the FW-a-TRIB2-FLAG (C) in our previous
study, Del-COP1 (plasmid expressing mutant TRIB2 protein with-
out the a.a. 324–343) is equivalent to the Del-C1-FLAG (C), and
Del-COP1/b-TrCP (plasmid expressing mutant TRIB2 protein
without a.a. 307–343) is equivalent to Del-C2-FLAG (C) in our
previous work [10]. The Smurf1-FLAG- and b-TrCP-FLAG-express-
ing plasmids were obtained from our previous work [10,13]. The
b-Catenin-Myc- and TCF4-Myc-expressing plasmids were gifts
from Dr. Xiangfan Liu (Shanghai Jiaotong University). The
COP1-FLAG-expressing plasmid was purchased from Origene
(Beijing, China).2.2. Immunoﬂuorescence (IF) and Western blotting (WB)
Cells were ﬁxed using 4% paraformaldehyde for 15 min for IF,
washed with PBS and blocking buffer (3% FBS + 1% HISS + 0.1% Tri-
ton X-100), and incubated overnight at 4 C in primary antibodies
against b-Catenin (Epitomics, Burlingame, CA, USA, #1247), COP1
(Abcam, Ab56400), b-TrCP (Cell Signaling Technology (CST),
Boston, MA, USA, #4394), Smurf1 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA, sc-100616), TCF4 (CST, #5174), TRIB2 (Abcam,
ab117981) or FLAG-Tag (CST, #8146 or #2368).
Subcellular extracts for WB were prepared using a kit from
Active Motif (Carlsbad, CA, USA). Proteins were resolved on SDS–
PAGE gels followed by standard WB. The following primary anti-
bodies were used: GAPDH (CST, #5174), HA-Tag (CST, #3724),
FLAG-tag (CST, #2368), TRIB2 (Abcam, Ab84683), b-Catenin
(Epitomics, #1247), COP1 (Abcam, Ab56400), b-TrCP (CST,
#4394), b-tubulin (CST, #2128), Histone (CST, 4499), Smurf1
(Santa Cruz Biotechnology, sc-100616), TCF4 (CST, #5174),
Myc-tag (CST, #2278) or Ub (CST, #3933).
2.3. Immunoprecipitation (IP)
The details of these procedures were described previously [10].
Anti-TRIB2 (Abnova, Taipei, Taiwan, #H00028951-M04) antibodies
were used for IP. IPs were washed at least ﬁve times and subjected
to WB analysis.
2.4. Luciferase reporter analysis
The pTOP-FLASH ﬁreﬂy luciferase reporters were co-transfected
with Renila luciferase expression plasmids (pRL-TK, Promega,
Madison, WI, USA) into the cells under the different indicated
treatments. The detection of luciferase activities was analyzed
using a dual-luciferase reporter kit (Promega).
2.5. Cell proliferation, soft-agar assays and quantitative RT-PCR (qPCR)
Cell proliferation was measured using an MTT-based prolifera-
tion assay as described previously [5]. Anchorage-independent
soft-agar growth assay and qRT-PCR were performed as previously
described [5]. The following primers were used for qPCR: Axin2-F:
ACAACAGCATTGTCTCCAAGCAGC, Axin2-R: GCGCCTGGTCAAACAT
GATGGAAT, SP5-F: CCGATGCGGCTACAGGT, SP5-R: CTGCAGGCCT
TTCTCCAG.
2.6. Ubiquitination assays
Cell lysates were prepared in Western/IP lysis buffer (Beyotime,
Haimen, China) supplemented with protease inhibitors (Roche,
Mannheim, Germany). Lysates were centrifuged at maximum
speed for 15 min, the supernatant was retrieved, and the amount
of protein was quantitated. Similar amounts of lysate were used
for IP with an anti-Myc tag antibody (CST, #2276) and protein A/
G beads (Novex, Oslo, Norway), which was performed at 4 C over-
night. The beads were washed in the same lysis buffer at least 5
times before boiling for 20 min in protein loading buffer (Beyo-
time). The eluted proteins were detected using anti-ubiquitin
(Ub) antibodies (CST, #3933) and standard WB.2.7. Xenograft mouse model
A total of 5  106 Bel-7402 cells infected with Empty or WT-
TRIB2-expressing lentivirus were subcutaneously injected into
athymic nude mice (Bikai, Shanghai, China). Tumor size was mea-
sured every 6 days using a caliper, and the tumor volume was
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ing width. Mice were sacriﬁced 42 days after injection. All of the
procedures involving animals and their care were performed in
accordance with institutional guidelines and compliance with laws
and policies.
3. Results
3.1. TRIB2 inhibits Wnt activity through a down-regulation
of b-Catenin and TCF4
We previously reported that the knockdown of a Wnt signaling
target, TRIB2 reduced cell proliferation and impaired transforma-
tive phenotype in the liver cancer cell lines, HepG2, Bel-7402 and
SMMC-7721 cells [5,10]. Here, we also tested endogenous Wnt sig-
naling activities in these cell lines using a pTOP-FLASH plasmid,
which is a luciferase reporter containing TCF response motifs,
and the data indicated that liver cancer cell lines HepG2,
Bel-7402 and SMMC-7721 have much higher Wnt signaling activ-
ities compared to the transformed hepatocyte line, HL-7702
(Fig. 1A). These results suggested that the activation of Wnt signal-
ing might contribute to liver tumorigenesis. HepG2 includes a
dominant active b-Catenin mutant, but Bel-7402 and SMMC-
7721 cells only contain wild-types (Fig. S1). Therefore, we chose
Bel-7402 and SMMC-7721 cells as the main research materials in
the present study to avoid mutation-induced interferences inFig. 1. TRIB2 inhibits Wnt activity through the down-regulation of b-Catenin/TCF4. (A) E
Bel-7402 and transformed hepatocyte HL-7702, as measured by pTOP-FLASH luciferase a
assay. (C) Anchorage-independent soft-agar colony formation in liver cancer cells infe
inhibited xenograft growth formed by Bel-7402 cells in vivo. Tumor volumes were m
activities from pTOP-FLASH reporter in control and TRIB2-overexpressed or knock-dow
TCF4- (F), b-Catenin- (G) or Axin2- (H) expressing plasmids with or without TRIB2 overex
with TRIB2 overexpression or knock down, as measured by qPCR assays. (J, K) b-Catenin
knock down (K). Data are shown as the means + S.D. from three independent experimenHepG2 cells. We investigated whether overexpression of TRIB2
had pro-oncogenic effects in Bel-7402 and SMMC-7721 cells. Sur-
prisingly, TRIB2 overexpression also decreased cell proliferation
(Fig. 1B), colony formation activity in soft agar (Fig. 1C) and
in vivo xenograft growth (Fig. 1D), which suggested that TRIB2
might act as a double-edged sword during tumorigenesis in liver
cancer cells.
Recently, we identiﬁed TRIB2 can be speciﬁcally regulated by
Wnt signaling in liver cancer cells [5]. We tested Wnt activity by
overexpressing and knocking down TRIB2 in cells transfected with
pTOP-FLASH to investigate whether TRIB2 exerted feedback on
Wnt activity. We found that luciferase activity was does-depen-
dently down-regulated by TRIB2 overexpression but up-regulated
by TRIB2 knockdown (Fig. 1E), which indicated a negative role of
TRIB2 on Wnt activity. However, TRIB2 was ineffective in the
pFOP-FLASH, which is a mutant reporter that contains all of the
regulatory elements of the pTOP-FLASH plasmid except the TCF
response motifs (data not shown). Furthermore, the TCF4-induced
up-regulation of Wnt activity was reversed by the simultaneous
overexpression of TRIB2 and enhanced by knockdown of TRIB2
(Fig. 1F). The results of b-Catenin were similar to TCF4 (Fig. 1G).
However, Axin2-reduced Wnt activity was not affected by TRIB2
overexpression or knockdown (Fig. 1H). Moreover, TRIB2 overex-
pression signiﬁcantly down-regulated the expression of the Wnt
targets SP5 and Axin2, whereas TRIB2 knockdown had the opposite
effects (Fig. 1I). These results further supported a negative role ofndogenous Wnt signaling activities in liver cancer cell lines, HepG2, SMMC-772 and
nalysis. (B) Overexpressing TRIB2 reduced cell proliferation, as measured by an MTT
cted with Empty or TRIB2-expressing lentivirus. (D) Ectopic expression of TRIB2
easured for 42 days after subcutaneous injection (n = 5 per group). (E) Luciferase
n cells. (F–H) Luciferase activities of pTOP-FLASH reporter in cells transfected with
pression or knockdown. (I) mRNA expression of SP5 and Axin2 in controls and cells
/TCF4 protein expression in Bel-7402 cells with either TRIB2 overexpression (J) or
ts. ⁄⁄P < 0.01 using Student’s t test.
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analysis revealed that the protein levels of b-Catenin and TCF4
were reduced by TRIB2 overexpression and induced by TRIB2
knockdown (Fig. 1J and K). These data suggested that
TRIB2-reduced Wnt activity might occur via down-regulation of
b-Catenin and TCF4.
3.2. TRIB2 reduces protein stability of b-Catenin/TCF4
Next, we investigated how TRIB2 regulates b-Catenin/TCF4.
Treatment of Bel-7402 cells with the protein synthesis inhibitor,
cycloheximide (CHX), reduced the stability of the b-Catenin and
TCF4 proteins. Moreover, TRIB2 overexpression led to a more rapid
degradation of these two proteins, which began 8 h post-CHX
treatment (Fig. 2A). However, TRIB2 did not inﬂuence b-Catenin
or TCF4 mRNA levels (data not shown), which excluded the possi-
bility that TRIB2 regulates either transcription or RNA stability of
b-Catenin and TCF4. In addition, TRIB2 still had negative effects
on luciferase activities from pTOP-FLASH in another liver cancer
cell line, Huh7, which also contains wild-type b-Catenin (Fig. S2).
Similar to Bel-7402 cells, CHX-induced protein degradation of
TCF4 and b-Catenin was also accelerated when TRIB2-FLAG was
overexpressed in SMMC-7721 and Huh7 cells (Fig. 2B), whichFig. 2. TRIB2 reduces protein stability of b-Catenin/TCF4. (A) Bel-7402 cells were stably
blocked by CHX treatment (50 lg/mL) for the indicated times. Relative b-Catenin/TC
experiments, and the data are shown in the lower panel. (B) TCF4 and b-Catenin protein e
with TRIB2-FLAG overexpression after treatment with CHX (50 lg/mL) for the indicated t
Myc (C) or TCF4-Myc (D) were co-transfected with TRIB2-FLAG into Bel-7402 cells. b-Cate
blotting analysis was performed using anti-Myc or anti-Ub Ab. (E, F) Co-localization of e
TRIB2-FLAG (F) in Bel-7402 cells as measured by microscopic analysis. Scale bar, 10 lM
TRIB2-FLAG-expressing plasmid. The arrow indicates cells transfected with TRIB2-FLAG,
(H) Subcellular fractions (equal protein) from Bel-7402 cells infected with either Empty
the indicated proteins.suggested that the negative effect of TRIB2 on Wnt activity is not
cell-speciﬁc.
Moreover, we detected a more signiﬁcant accumulation of ubiq-
uitinated exogenous b-Catenin-Myc compared to control when
TRIB2-FLAG was co-transfected (Fig. 2C). Similar ubiquitination
effects by TRIB2-FLAG on exogenous TCF4-Myc were also detected
(Fig. 2D), which suggested that TRIB2 facilitates ubiquitination of
b-Catenin and TCF4.
Microscopic analysis demonstrated that endogenous TRIB2 was
mainly located in the nucleus and co-localized with TCF4 but not
b-Catenin in Bel-7402 cells at basal levels (Fig. 2E). Co-transfection
of exogenous TCF4-Myc or b-Catenin-Myc with TRIB2-FLAG
revealed that TRIB2-FLAG co-localized with TCF4-Myc in the
nucleus (Fig. 2F). However, unlike endogenous b-Catenin, exoge-
nous b-Catenin-Myc exhibited strong nuclear co-localization
signals with exogenous TRIB2-FLAG (Fig. 2F). We then tested
whether TRIB2 overexpression affected the subcellular localization
of endogenous b-Catenin and TCF4. TRIB2 overexpression did not
alter the nuclear localization of TCF4. In contrast, nuclear recruit-
ment of b-Catenin was detected in cells transfected with exoge-
nous TRIB2-FLAG compared to cells without successful
transfection (Fig. 2G). Fractionation studies further conﬁrmed that
TRIB2 overexpression facilitated b-Catenin localization from thetransfected with Empty or TRIB2-FLAG-expressing vectors. Protein synthesis was
F4 protein levels were quantiﬁed by ratios to GAPDH from three independent
xpression in control (infected with empty lentivirus) and SMMC-7721 or Huh7 cells
imes. (C, D) TRIB2-induced ubiquitination of b-Catenin/TCF4. Exogenous b-Catenin-
nin/TCF4-Myc were immunoprecipitated by anti-Myc antibodies (Ab), and Western
ndogenous b-Catenin/TCF4 and TRIB2 (E) and exogenous b-Catenin/TCF4-Myc and
. (G) Subcellular localization of b-Catenin/TCF4 in Bel-7402 cells transfected with a
while the asterisk indicates cells without successful transfection. Scale bar, 10 lM.
or TRIB2-FLAG-expressing lentivirus were subjected to Western blotting analysis of
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did not inﬂuence TCF4 translocation (Fig. 2H). These results led us
to propose that the regulation of b-Catenin/TCF4 protein stability
by TRIB2 occurs in the nucleus.
3.3. TRIB2-associated E3 ligases play critical roles in the regulation
of b-Catenin and TCF4
TRIB2 acts as an adapter protein that is functionally important
to ubiquitin E3 ligases, such as b-TrCP, COP1 and Smurf1 [3,5,8–
10]. Therefore, we hypothesized that these E3 ligases mediate
b-Catenin and TCF4 protein degradation. We ﬁrst examined the
subcellular localization of these E3 ligases and found that all three
tested E3 ligases exhibited nuclear localization signals (Fig. 3A).
We further revealed that the nuclear expression of b-TrCP, COP1
and Smurf1 was signiﬁcantly elevated in Bel-7402 cells transfected
with TRIB2-FLAG-expressing plasmids (over 90 cells per 100
TRIB2-FLAG-positive cells counted showed enhanced-nuclear
expression of these three E3 ligases) compared to cells without
successful transfection (Fig. 3B and C). These results suggested that
TRIB2 enhances the activities of these E3 ligases in the nucleus.
Fractionation studies also demonstrated that the up-regulation ofFig. 3. TRIB2 exists in a scaffold complex with its associated E3 ligases. (A) Subcellular
cells. Scale bar, 10 lM. (B) Subcellular localization of b-TrCP, COP1 and Smurf1 in Bel-74
indicates cells transfected with TRIB2-FLAG, while the asterisk indicates cells without suc
COP1 or Smurf1 nuclear expression, as indicated in panel B, was counted in 100 cells w
three independent tests. (D) Subcellular fractions (equal protein) from Bel-7402 cells i
Western blotting analysis for the indicated proteins. (E) The relative TRIB2 protein expre
ratio between TRIB2 and an internal loading control protein (Histone, b-tubulin or GAPDH
and its associated E3 ligases. Endogenous TRIB2 from Bel-7402 cells was immunoprecipi
or Smurf1 was shown by anti-COP1, anti-b-TrCP or anti-Smurf1 Western blotting. A conb-TrCP, COP1 and Smurf1 expression was seen in nuclear lysates,
whereas the down-regulation of these E3 ligases was seen in cyto-
solic lysates after TRIB2 overexpression (Fig. 3D). However, overex-
pression of exogenous TRIB2-FLAG only proportionally increased
endogenous TRIB2 in nuclear and cytosolic lysates (Fig. 3D and
E), which indicated that TRIB2 overexpression does not induce
TRIB2 trafﬁcking from the cytoplasm to the nucleus. Previous stud-
ies [5,9,10] demonstrated that TRIB2 interacts with Smurf1, COP1
and b-TrCP. Here, we also found that three E3 ligases, Smurf1,
COP1 and b-TrCP, were detected by corresponding antibodies in
the immunoprecipitates pulled down by anti-TRIB2 antibodies
(Fig. 3F), which suggested that TRIB2 and all three E3 ligases bind
together in one complex.
We tested whether b-TrCP, COP1 and Smurf1 had similar nega-
tive effects as TRIB2 onWnt activity. We found that overexpression
of b-TrCP, COP1 and Smurf1 reversed b-Catenin- and TCF4-
induced-up-regulation of Wnt activity (Fig. 4A). Furthermore,
simultaneous overexpression of TRIB2 and COP1, b-TrCP or Smurf1
had a much stronger inhibitory effect on b-Catenin and TCF4 pro-
tein expression than the overexpression of these E3 ligases alone
(Fig. 4B, D and F), which suggested that TRIB2 has a synergistic role
with its associated E3 ligases. In contrast, knockdown of these E3localization of endogenous b-TrCP, COP1 and Smurf1 in Bel-7402 and SMMC-7721
02 cells with or without transfection of TRIB2-FLAG-expressing plasmids. The arrow
cessful transfection. Scale bar, 10 lM. (C) The number of cells with enhanced b-TrCP,
ith successful transfection of TRIB2-FLAG. Data are shown as the means + S.D. from
nfected with either Empty or TRIB2-FLAG-expressing lentivirus were subjected to
ssion in different subcellular fractions, as indicated in panel D, was quantiﬁed as the
) from three independent experiments. (F) Interactions between endogenous TRIB2
tated with anti-TRIB2 antibodies (Ab), and co-immunoprecipitation of COP1, b-TrCP
trol IgG was used as the negative control for immunoprecipitation.
Fig. 4. TRIB2-associated E3 ligases exert negative roles on b-Catenin/TCF4. (A) Luciferase activities from pTOP-FLASH in Bel-7402 cells transfected with different plasmids as
indicated. Data are shown as the means + S.D. from three independent experiments. ⁄⁄P < 0.01 using Student’s t test. (B–G) b-Catenin/TCF4 expression in control and Bel-7402
cells under different treatments as indicated.
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G). Taken together, TRIB2-associated E3 ligases reduced-Wnt activ-
ity was also through down-regulation the expression of b-Catenin
and TCF4.
3.4. Deletion of the binding region of the E3 ligase impairs TRIB2
function
As previously reported [5,9,10], the binding region of Smurf1
encompasses amino acids (a.a.)1–5 in the TRIB2 protein. The bind-
ing region of b-TrCP encompasses TRIB2 a.a. 307–323, and the
binding region of COP1 encompasses TRIB2 a.a. 324–343
(Fig. 5A). We deleted these regions and tested whether these
regions are critical for the TRIB2-induced degradation of b-Catenin
and TCF4. These mutant TRIB2 proteins failed to reduce b-Catenin/
TCF4 protein expression compared to wild-type (WT) TRIB2
(Fig. 5B). Luciferase activities of pTOP-FLASH were also compro-
mised because only WT-TRIB2 had negative effects (Fig. 5C).
Furthermore, TRIB2 mutants were unable to induce an accumula-
tion of ubiquitination of exogenous b-Catenin-Myc or TCF4-My
compared to the WT (Fig. 5D and E). In addition, the translocation
of b-Catenin into the nucleus was abolished after deletion of the
COP1, b-TrCP or Smurf1 binding regions (Fig. S3). Consistent with
the WT, the mutant TRIB2 had no effects on the subcellular
localization of TCF4 (Fig. S3).
As described above, WT-TRIB2 induced a nuclear accumulation
of b-TrCP, COP1 and Smurf1 (Fig. 3B–D). Here, we tested whether
deletion of the E3 ligase-binding regions inﬂuenced their expres-
sion. Mutant TRIB2 without a Smurf1 binding region did no inﬂu-
ence on the nuclear expression of Smurf1, and this mutant still
enhanced the nuclear accumulation of COP1 and b-TrCP (Fig. 5F).
Similarly, mutant TRIB2 without a COP1 binding region did not
affect the nuclear accumulation of COP1, and it was effective on
b-TrCP and Smurf1 (Fig. 5G). Furthermore, mutant TRIB2 without
both COP1 and b-TrCP binding regions only affected the nuclear
expression of Smurf1 (Fig. 5H). These results suggested that the
E3 ligase-binding regions within the TRIB2 protein are fundamen-
tally important to the TRIB2-mediated regulation of the
corresponding E3 ligases.4. Discussion
We previously reported that depletion of TRIB2 impaired the
transformative phenotype of liver cancer cells [5,10]. The present
study demonstrated a similar reduction in tumorigenicity as a
result of TRIB2 overexpression. These results implicate TRIB2 as a
double-edged sword during liver tumorigenesis, because TRIB2
can be either oncogenic or tumor suppressive. However, TRIB2 is
not an individual event. For example, NKX2-1/TTF-1 plays a role
as a ‘‘lineage-survival’’ oncogene in lung adenocarcinomas, but it
also has opposite biological and clinical functions that act against
tumor progression [14]. Recent studies indicate that Notch signal-
ing is another example of dual pro- and anti-tumorigenic properties
depending on the cellular context [15]. The current and previous
studies [5,9,10] suggest that TRIB2 plays different roles in different
signaling pathways, and these effects may largely depend on
whether the signaling node that can be regulated by TRIB2 is pro-
tumorigenic or anti-tumorigenic. TRIB2 promotion of tumorigene-
sis may occur at least through two signaling pathways: the
Hippo/YAP pathway, in which the terminal effector YAP is cancer
promoting and can be protected by TRIB2 from proteasome-medi-
ated degradation [5], and a C/EBPa-involved pathway, in which
the effecter C/EBPa is cancer suppressing and its degradation is
enhanced by TRIB2 [3,7,8]. We also revealed here that TRIB2 might
simultaneously suppress tumors through the inhibition of another
signaling pathway, Wnt signaling. Wnt signaling plays an impor-
tant role in cancer pathogenesis, and it has been studied as a poten-
tial target for cancer therapy [16]. Therefore, blockade of Wnt
signaling would be a reasonable strategy for liver cancer therapy.
Recently, an antibody-directed therapy against the heparan sulfate
of a proteoglycan showed efﬁcacy in Wnt signaling blockade and
liver cancer growth [17]. However, heparan sulfate proteoglycans
(HSPGs) are ubiquitously expressed on the cell surface and extra-
cellular matrix (ECM) in animals [18]. TRIB2 can be speciﬁcally reg-
ulated by Wnt signaling in liver cancer cells [5], and it can
conversely inhibit Wnt activity. Therefore, a strategy that combines
monoclonal antibody targeting of the extracellular components of
Wnt signaling with pharmaceutical activation of TRIB2 may lead
to a more liver cancer-speciﬁc and effective therapeutic approach.
Fig. 5. Deletion of E3 ligase binding regions impairs TRIB2 function. (A) Illustration of E3 ligase binding regions within the TRIB2 protein. (B, C) b-Catenin/TCF4 expression (B)
and luciferase activity from pTOP-FLASH reporter (C) in Bel-7402 cells transfected with empty, WT-TRIB2 or mutant-TRIB2-expressing plasmids as indicated. (D, E) Deletion
of E3 ligase binding regions abolished ubiquitination of b-Catenin/TCF4. Exogenous b-Catenin-Myc (D) or TCF4-Myc (E) were co-transfected with WT or mutant TRIB2-FLAG,
as indicated, into Bel-7402 cells. b-Catenin/TCF4-Myc were immunoprecipitated by anti-Myc antibodies (Ab), and Western blotting analysis was performed using anti-Myc or
anti-Ub Ab. (F, H) Subcellular localization of b-TrCP, COP1 and Smurf1 in Bel-7402 cells with or without transfection with Del-Smurf1–TRIB2-FLAG (F), Del-COP1–TRIB2-FLAG
(G) or Del-COP1/b-TrCP–TRIB2-FLAG (H). The arrow indicates cells transfected with TRIB2-FLAG, while the asterisk indicates cells without successful transfection. Scale bar,
20 lM.
Fig. 6. Possible mechanism underlying TRIB2 inhibition of Wnt activity through down-regulation of b-Catenin/TCF4 expression in liver cancer cells.
4340 S. Xu et al. / FEBS Letters 588 (2014) 4334–4341TRIB2-reduced Wnt activity relied on the function of b-TrCP,
COP1 and Smurf1. However, only b-TrCP has been revealed directly
involved in the degradation of b-Catenin [11,19]. Interestingly, onerecent study uncovered Smurf1 as a new negative regulator of Wnt
signaling through the targeting of the Axin protein for non-prote-
olytic ubiquitination [20]. Our data add new evidence that Smurf1
S. Xu et al. / FEBS Letters 588 (2014) 4334–4341 4341participates in the TRIB2-mediated down-regulation of Wnt signal-
ing activity. To the best of our knowledge, we are also the ﬁrst to
report COP1 as a negative regulator of Wnt signaling. TRIB2 con-
tains three E3 ligase binding regions that interact with b-TrCP,
COP1 and Smurf1. Deletion of one of these binding regions abol-
ished TRIB2-reducedWnt activity and the accumulated ubiquitina-
tion of b-Catenin and TCF4, which suggests that TRIB2, b-TrCP,
COP1 and Smurf1 may scaffold into a complex and each compo-
nent may serve as an essential and indispensable regulator of
Wnt activity. TRIB2 per se has the ability to induce the nuclear
accumulation of its associated E3 ligases, which indicates that
TRIB2 plays a central role in the self-enhancement of the complex.
However, overexpression of exogenous TRIB2 did not alter the sub-
cellular localization of endogenous TRIB2. This result suggests that
the nuclear accumulation of E3 ligases is rather like an event trig-
gered by TRIB2 overexpression, but it is not directly dependent on
TRIB2 per se. TRIB proteins reportedly interact with various signal-
ing molecules and transcription factors, including activating tran-
scription factor 4 (ATF4), p65, C-terminal interacting protein
(CtIP), mitogen-activated protein kinase kinase (MAPKK), and pro-
tein kinase B (AKT) [9]. However, whether and how TRIB2 overex-
pression-induced nuclear accumulation of its associated E3 ligases
depends on the above or other factors needs to be further
investigated.
Nuclear accumulation of b-Catenin is a hallmark of Wnt activa-
tion [21]. However, TRIB2 overexpression-enhanced nuclear accu-
mulation of b-Catenin cannot account for the activation of Wnt, but
it is a prerequisite to ease the interaction between b-Catenin/TCF4
and TRIB2-associated E3 ligases. Further mechanisms underlying
how b-Catenin and TCF4 shuttle from activation to inhibition need
to be explored.
The study is limited because we used non-denaturation IP
for the detection of ubiquitination of b-Catenin/TCF4 and therefore
we cannot rule out the possibility that the ubiquitination we
saw is due to the ubiquitination of another protein that was
present in the lysate. This situation will be improved in our future
study.
In conclusion, we have uncovered a new role of TRIB2 in the
inhibition of Wnt activity. TRIB2 facilitates the nuclear accumula-
tion of its associated E3 ligases and b-Catenin, which provides a
platform that promotes the ubiquitination of b-Catenin and
TCF4 in liver cancer cells (Fig. 6). Therefore, we established a novel
negative auto-regulatory feedback in which TRIB2 is a downstream
effector and upstream negative regulator of Wnt signaling.Conﬂict of interest statement
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